Combine supplements of OptiPEAK T Lymphocyte media. Isolate human T lymphocytes from whole blood. Wash to remove traces of donor serum. Activate and expand T lymphocytes (7-10 days) in OptiPEAK T Lymphocyte serum free media. Harvest T lymphocytes. Perform post-expansion, flow cytometric analysis of phenotypic surface markers.
Posted By Annie Cunningham on 2/18/19 8:41 AM
Posted By Randy Alfano Ph.D. on 2/4/19 8:36 AM
In January, there's no better place to be than Miami, FL. While we were excited to escape the cold winter, it was all business for InVitria during Phacilitate 2019 and the Regenerative Medicine Foundation’s World Stem Cell Summit. This year, there was an excitement in the air due to the significant increase in the number of cell therapies in the clinical pipeline. With some cell therapies already being approved, many product innovators at the conference were beginning to focus toward commercial scale-up, bringing new learnings and innovations to the industry. Overall, this event was a big success for our cell culture media team since it was packed with great content, speakers and many partnering meetings.
January 27th - 31st InVitria will be in California for Engineering Conferences International: Advancing Manufacturing Cell & Gene Therapy VI. This unique conference will focus on the technological challenges and engineering solutions in the cell and gene therapy field. Limited to 400 participants, this conference is an opportunity for key academic and industrial leaders in the space to showcase and discuss new and existing approaches.
January 22nd - 25th InVitria will be in Miami for the Phacilitate Leaders World and World Stem Cell Summit. These meetings bring together leaders and researchers from every major stakeholder group in the advanced therapies ecosystem. This year we're excited to talk to and hear presentations from the 2,000 attendees, 150 exhibitors and 300 speakers in attendance.